Nosa Plugs (NOSA) CMD 2025 summary

Updated strategy and objectives for 2025-2026

• Targets profitability from Q4 2025, with a primary goal of achieving positive EBITDA.

• Focuses on strong growth in the core business, acquiring attractive ENT brands, and forming drug delivery partnerships.

• Expands business definition from "intra nasal breathing devices" to "nasal health," aiming for market leadership.

• Plans to broaden the product portfolio through acquisitions and rollout of Smell training and Nozoil in more European markets.

• Increased emphasis on leveraging the distribution network, salesforce efficiency, and odor control tenders to boost earnings and customer loyalty.

Strategic transformation and market positioning

• Aims to fill market gaps with high-margin growth opportunities by expanding the product range.

• Seeks to be a leader in niche markets, building strong competitive barriers and relevance for distributors and end customers.

• Enhanced profitability in the core business will enable self-financing of development projects and acquisitions.

• The updated strategy is a key step toward profitable growth and leadership in nasal health and related areas.

Financial and operational ambitions

• Intends to become self-sustaining and create greater shareholder value once profitable.

• Focus on operational efficiency and market expansion to drive sustainable, profitable growth.